Literature DB >> 10500516

Antibiotics for upper respiratory tract infections. Follow-up utilization and antibiotic use.

W J Hueston1, A G Mainous, S Ornstein, Q Pan, R Jenkins.   

Abstract

OBJECTIVES: To examine the effects of antibiotic prescribing during an initial visit for viral respiratory tract infections on future care seeking and the cost of care.
MATERIALS AND METHODS: Retrospective analysis of recorded visits for viral respiratory tract infections (N = 49,862) between January 1, 1995, and December 31, 1997, to practices in a large network of affiliated practices that use the same electronic medical record.
RESULTS: Patients receiving antibiotics at the initial visit were less likely to return for a second visit, but this difference was small (15.4% vs 17.4%, P < .001). When returning for the second visit, those who received an antibiotic on the initial visit were prescribed more expensive antibiotics than those who had not received an antibiotic on the initial consultation. Overall, cost from initial antibiotic use outweighed any benefit from reduced utilization in adults and children.
CONCLUSIONS: Antibiotic prescribing at an initial contact for a viral respiratory tract illness may reduce the likelihood that an individual will return for a subsequent visit, but adds substantial costs to care for the initial antibiotic and for more expensive antibiotics used on subsequent visits.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500516     DOI: 10.1001/archfami.8.5.426

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  5 in total

1.  Early detection of acute rhinovirus infections by a rapid reverse transcription-PCR assay.

Authors:  C Steininger; S W Aberle; T Popow-Kraupp
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Inappropriate Antibiotic Prescribing for Acute Bronchitis in Children and Impact on Subsequent Episodes of Care and Treatment.

Authors:  Jake R Morgan; Kathleen M Carey; Tamar F Barlam; Cindy L Christiansen; Mari-Lynn Drainoni
Journal:  Pediatr Infect Dis J       Date:  2019-03       Impact factor: 2.129

3.  Statin-macrolide interaction risk: a population-based study throughout a general practice database.

Authors:  Nadia Piacentini; Gianluca Trifiró; Michele Tari; Salvatore Moretti; Vincenzo Arcoraci
Journal:  Eur J Clin Pharmacol       Date:  2005-07-26       Impact factor: 2.953

4.  Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Marty S Player; James M Gill; Heather Bittner Fagan; Arch G Mainous
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

5.  Drugs in upper respiratory tract infections in paediatric patients in North Trinidad.

Authors:  Kameel Mungrue; Tessa Brown; Ivory Hayes; Savatri Ramroop; Portio Thurston; Lexley Pinto Pereira
Journal:  Pharm Pract (Granada)       Date:  2009-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.